Use of modified RECIST criteria to improve response assessment in targeted therapies: challenges and opportunities
- PMID: 20023419
- DOI: 10.4161/cbt.9.1.10716
Use of modified RECIST criteria to improve response assessment in targeted therapies: challenges and opportunities
Comment on
-
CT response assessment combining reduction in both size and arterial phase density correlates with time to progression in metastatic renal cancer patients treated with targeted therapies.Cancer Biol Ther. 2010 Jan;9(1):15-9. doi: 10.4161/cbt.9.1.10340. Epub 2010 Jan 17. Cancer Biol Ther. 2010. PMID: 20009542
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources